Study on the clinical effects and brain function regulation mechanism of Baduanjin intervention for chronic insomnia

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Baduanjin group:Baduanjin;Cognitive behavioral therapy group:Cognitive behavioral therapy ;Healthy people group:None; CONDITION: Chronic insomnia PRIMARY OUTCOME: Pittsburgh Sleep Quality Index; SECONDARY OUTCOME: Hyperarousal Scale;Isomnia Severity Index;Salivary Cortisol;Actigraphy;Resting‐state functional magnetic resonance;Fatigue Scale‐14;Hamilton Depression Scale; INCLUSION CRITERIA: 1. Inclusion criteria of experimental group: (1) Patients meeting the diagnostic criteria for chronic insomnia; (2) ISI scale score 7‐21; (3) HAMD scale score <=14; (4) Aged between 18 and 65 years, no gender limit; (5) Routine blood and urine tests and liver and kidney function no abnormal; (6) Right‐handed; (7) Agree and sign the informed consent. 2. Inclusion criteria of control group: (1) Patients without insomnia symptoms; (2) Do not suffer from related diseases that may cause insomnia; (3) Routine blood and urine tests and liver and kidney function no abnormal; (4) Those who agreed to maintain a normal sleep schedule and not engage in activities that may lead to chronic insomnia during the study; (5) Aged between 20 and 60 years, no gender limit.
Epistemonikos ID: 8aa79c92bacfc2d5e25f451bce9d5ad22a8baf27
First added on: Feb 20, 2024